MEDICATION OR OTHER SUBSTANCE
|
|
- Oswin Manning
- 5 years ago
- Views:
Transcription
1 Patient Safety Event Report Hospital MEDICATION OR OTHER SUBSTANCE Use this form to report any patient safety event or unsafe condition involving a substance such as a medications, biological products, nutritional products, expressed human breast milk, medical gases, or contrast media. Do not complete this form if the event involves appropriateness of therapeutic choice or decision making (e.g., physician decision to prescribe medication despite known drug-drug interaction). If the event involves a device, please also complete the Device or Medical/Surgical Supply including Health Information Technology (HIT) form. Narrative detail can be captured on the Healthcare Event Reporting Form (HERF). Highlighted fields are collected for local facility and PSO use. This information will not be forwarded to the Network of Patient Safety Databases (NPSD). 1. DE270 What type of medication/substance was involved? a. A1197 Medications 2. DE273 What type of medication? a. A1218 Prescription or overthe-counter (including herbal supplements) b. A1221 Compounded preparations c. A1224 Investigational drugs d. UNK Unknown 3. DE276 Please list all ingredients: b. A1200 Biological products 4. DE279 What type of biological product? a. A1233 Vaccines b. A1236 Other biological products (e.g., thrombolytic) 5. DE282 What was the lot number of the vaccine? LOT NUMBER c. A1203 Nutritional products d. A1206 Expressed human breast milk e. A1209 Medical gases (e.g., oxygen, nitrogen, nitrous oxide) f. A1212 Contrast media 6. DE285 What type of nutritional product? a. A1242 Dietary supplements (other than vitamins or minerals) b. A1245 Vitamins or minerals c. A1248 Enteral nutritional products, including infant formula d. A1251 Parenteral nutritional products e. A66 Other: PLEASE SPECIFY g. A1213 Radiopharmaceuticals h. A1214 Patient food (not suspected in drug-food interactions) i. A1216 Drug-drug, drug-food, or adverse drug reaction as a result of a prescription and/or administration of a drug and/or food prior to admission j. A1215 Other substance: PLEASE SPECIFY STOP This form is complete. Page 1 of 5
2 7. DE288 Which of the following best characterizes the event? a. A1257 Incorrect action (process failure or error) (e.g., such as administering overdose or incorrect medication) b. A1260 Unsafe condition ANSWER QUESTIONS c. A1263 Adverse reaction in patient to the administered substance without any apparent incorrect action d. UNK Unknown STOP This form is complete. 8. DE291 What was the incorrect action? CHECK ALL THAT APPLY: a. A585 Incorrect patient b. A1272 Incorrect medication/substance c. A1275 Incorrect dose(s) d. A1278 Incorrect route of administration 9. DE294 Which best describes the incorrect dose(s)? a. A1314 Overdose b. A1317 Underdose c. A1320 Missed or omitted dose d. A1323 Extra dose e. UNK Unknown e. A1281 Incorrect timing 10. DE297 Which best describes the incorrect timing? a. A1329 Too early b. A1332 Too late f. A1284 Incorrect rate 11. DE300 Which best describes the incorrect rate? a. A1338 Too quickly b. A1341 Too slowly g. A1287 Incorrect duration of administration or course of therapy h. A1290 Incorrect dosage form (e.g., sustained release instead of immediate release) i. A1293 Incorrect strength or concentration j. A1296 Incorrect preparation, including inappropriate cutting of tablets, error in compounding, mixing, etc. k. A1299 Expired or deteriorated medication/substance l. A1302 Medication/substance that is known to be an allergen to the patient 12. DE303 Which best describes the incorrect strength or concentration? a. A1347 Too high b. A1350 Too low 13. DE306 What was the expiration date? 14. DE309 Was there a documented history of allergies or sensitivities to the medication/substance administered? / / MM DD YYYY Page 2 of 5
3 m. A1305 Medication/substance that is known to be contraindicated for the patient 15. DE312 What was the contraindication (potential or actual interaction)? a. A1368 Drug-drug b. A1371 Drug-food c. A1374 Drug-disease d. A66 Other: PLEASE SPECIFY n. A1308 Incorrect patient/family action (e.g., self-administration error) o. A66 Other: PLEASE SPECIFY 16. E315 At what stage in the process did the event originate, regardless of the stage at which it was discovered? a. A1380 Purchasing b. A1383 Storing c. A1386 Prescribing/ordering d. A1389 Transcribing e. A1392 Preparing f. A1395 Dispensing g. A1398 Administering h. A1401 Monitoring i. UNK Unknown j. A66 Other: PLEASE SPECIFY QUESTIONS DO NOT APPLY TO COMPOUNDED PREPARATION OR EXPRESSED HUMAN BREAST MILK FOR AN INCIDENT, ANSWER QUESTIONS FOR A NEAR MISS, ANSWER QUESTIONS FOR AN UNSAFE CONDITION, ANSWER QUESTIONS Page 3 of 5
4 Please provide the following medication details for any medications or other substances directly involved in the event. 17. DE318 Generic name or investigational drug name 18. DE319 Ingredient RXCUI 19. DE321 Brand name 20. DE322 Brand name RXCUI (if known) 21. DE324 Manufacturer 22. DE327 Strength or concentration of product DE328 Clinical drug component RXCUI 24. DE330 Dosage form of product 25. DE331 Dose form RXCUI (if known) 26. DE333 Was this medication/ substance prescribed for this patient? 27. DE336 Was this medication / substance given to this patient? IF THIS EVENT DID NOT INVOLVE AN INCORRECT ROUTE OF ADMINISTRATION STOP This form is complete. IF THE EVENT INVOLVED AN INCORRECT ROUTE OF ADMINISTRATION, ANSWER QUESTIONS Page 4 of 5
5 28. DE348 What was the intended route of administration? a. A1440 Cutaneous, topical application, including ointment, spray, patch b. A1443 Subcutaneous c. A1444 Ophthalmic d. A1446 Oral, including sublingual or buccal e. A1447 Otic f. A1449 Nasal g. A1450 Inhalation h. A1452 Intravenous i. A1455 Intramuscular j. A1458 Intrathecal k. A1461 Epidural l. A1464 Gastric m. A1467 Rectal n. A1470 Vaginal o. UNK Unknown p. A66 Other: PLEASE SPECIFY _ 29. DE351 What was the actual route of administration (attempted or completed)? a. A1440 Cutaneous, topical application, including ointment, spray, patch b. A1443 Subcutaneous c. A1444 Ophthalmic d. A1446 Oral, including sublingual or buccal e. A1447 Otic f. A1449 Nasal g. A1450 Inhalation h. A1452 Intravenous i. A1455 Intramuscular j. A1458 Intrathecal k. A1461 Epidural l. A1464 Gastric m. A1467 Rectal n. A1470 Vaginal o. UNK Unknown p. A66 Other: PLEASE SPECIFY _ Thank you for completing these questions. OMB No Exp. Date 12/31/2017 Public reporting burden for the collection of information is estimated to average 10 minutes per response. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to: AHRQ Reports Clearance Officer, Attention: PRA, Paperwork Reduction Project ( ) AHRQ, 5600 Fishers Lane, # 07W41A, Rockville, MD Page 5 of 5
MEDICATION OR OTHER SUBSTANCE
Patient Safety Event Report Hospital MEDICATION OR OTHER SUBSTANCE Use this form to report any patient safety event or unsafe condition involving a substance such as a medications, biological products,
More informationSURGERY OR ANESTHESIA
Patient Safety Event Report Hospital SURGERY OR ANESTHESIA Use this form to report an event involving a surgical or other invasive procedure (e.g., colonoscopy), or the administration of anesthesia. Do
More informationMOST Operations Manual page 1 MEDICATION INVENTORY TABLE OF CONTENTS
MOST Operations Manual page 1 TABLE OF CONTENTS MEDICATION INVENTORY 1. Background and rationale...2 2. Equipment and supplies...2 3. Detailed measurement procedures...2 3.1 Targeted medications...2 3.2
More informationMOST Operations Manual page 1 MEDICATION INVENTORY
MOST Operations Manual page 1 TABLE OF CONTENTS MEDICATION INVENTORY 1. Background and rationale... 2 2. Equipment and supplies... 2 3. Detailed measurement procedures... 2 3.1 Drug definition guidelines...
More informationFDB FOOD AND DRUGS BOARD G H A N A GUIDELINES FOR CONDUCTING BIOEQUIVALENCE STUDIES
FDB FOOD AND DRUGS BOARD G H A N A GUIDELINES FOR CONDUCTING BIOEQUIVALENCE STUDIES 1 SCOPE In pursuance of section 47 of the Food and Drugs Law 1992, P.N.D.C.L 305B, as amended by Act 523, 1996, these
More informationChapter 7. Principles of Pharmacology
Chapter 7 Principles of Pharmacology Introduction Administering medications is a serious business. Medications may alleviate pain and improve patient s well-being. Used inappropriately, may cause harm
More informationHCHS/SOL Medication Use Questionnaire
Public reporting burden for this collection of information is estimated to average 06 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and
More informationBrand and Generic Drugs. Educational Objectives. Absorption
Peter J. Rice, PharmD, PhD Associate Professor of Pharmacology East Tennessee State University Educational Objectives Pharmacokinetic Processes Distribution Metabolism Excretion Similarities Active ingredient(s)
More informationChapter 7. National EMS Education Standard Competencies (1 of 5) National EMS Education Standard Competencies (2 of 5) Principles of Pharmacology
Chapter 7 Principles of Pharmacology National EMS Education Standard Competencies (1 of 5) Pharmacology Applies fundamental knowledge of the medications that the EMT may assist/administer to a patient
More information2014 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older)
2014 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) Physician Name: Patient Name: Last First MI Date of Birth: / / mm dd yyyy Gender: M F Medical Record
More informationGuidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.
Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry DRAFT GUIDANCE This guidance
More informationPHARMACY BENEFITS MANAGER
PHARMACY BENEFITS MANAGER CU GME Benefits Office Prescriptions should be obtained at participating pharmacies using your Benefits ID card. A list of participating pharmacies may be obtained by calling
More informationMedication Administration. By: Carolyn McCune RN, BSN, MSN, CRNP
Medication Administration By: Carolyn McCune RN, BSN, MSN, CRNP Percutaneous Administration Medications application to the skin or mucus membranes Ointments, creams, powders, lotions, solutions into the
More informationIntroduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D
Introduction to 1 Pharmacokinetics University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 2 Learning objectives Understand compartment models and how they effects
More informationRoutes of drug administration
Routes of drug administration Definition:- A route of administration in pharmacy is the path by which a drug is taken into the body. Classification:- The various routes of administrations are classified
More informationBasic Pharmacology. Drugs
Basic Pharmacology Drugs Basic Principles Study of drugs Actions Dosage Therapeutic uses (indications) Adverse effects Directly linked to the pathophysiology of a particular disease Drug = a substance
More information2015 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older)
2015 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered satisfactory
More informationChapter 11 - Principles of Pharmacology
1 2 3 4 5 6 7 8 9 Chapter 11 Principles of Pharmacology National EMS Education Standard Competencies (1 of 5) Pharmacology Applies fundamental knowledge of the medications that the EMT may assist/administer
More informationClinical Studies in BE Evaluation of Generic Products. Brenda S. Gierhart, M.D. Medical Officer, Division of Clinical Review, Office of Generic Drugs
Clinical Studies in BE Evaluation of Generic Products Brenda S. Gierhart, M.D. Medical Officer, Division of Clinical Review, Office of Generic Drugs 1 Disclaimer The opinions and information in this presentation
More informationDrug Prescription and Administration Record
Chart No. this admission Drug Prescription and Administration Record Patient s Name: of Admission: Chart Start : Chart Finish : NHS No: Consultant Code: Ward: ALERT: of Birth: ADDITIONAL CAUTIONS FOR PRESCRIBING
More informationMedication Safety Presentation
Appendix E Aid 1: Sample Event Poster Medication Safety Presentation Do YOU know your role on the healthcare team? Do YOU know the questions to ask your pharmacist? Do YOU know safe medication practices?
More informationAgency 71. Kansas Dental Board (Authorized by K.S.A and (Authorized by K.S.A and
Agency 71 Kansas Dental Board Articles 71-4. CONTINUING EDUCATION REQUIREMENTS. 71-5. SEDATIVE AND GENERAL ANAESTHESIA. 71-11. MISCELLANEOUS PROVISIONS. Article 4. CONTINUING EDUCATION REQUIREMENTS 71-4-1.
More informationMOD 4: Medication Administration
NSE22 Page 1 1. MOD 4: Medication Administration October1310 8:12 PM The CNO identifies eight rights of medication administration. Identify the eight rights and the rationale for each Right Client give
More informationnisterine Medications
nisterine Medications Pharmacology for Health Careers sixth edition Donna F. Gauwitz, R.N., M.S. Nursing Consultant Former Senior Teaching Specialist School of Nursing University of Minnesota Minneapolis,
More informationDraft Guideline on Pharmaceutical Development of Medicines for Paediatric Use. C. Nopitsch-Mai London 1
Draft Guideline on Pharmaceutical Development of Medicines for Paediatric Use C. Nopitsch-Mai 08-11-2011 London 1 Content - Background - Pharmaceutical Problems - Scope - Characterisation of the Active
More informationChloroform Codeine Ether
1 2 3 4 5 6 7 8 9 10 11 12 13 14 Chapter 6, Part 1 GENERAL PRINCIPLES OF PHARMACOLOGY Part 1 Basic Pharmacology Drugs are chemicals used to diagnose, treat, and disease. Pharmacology is the study of drugs
More informationEducation Program for Prescribers and Pharmacists
Transmucosal Immediate Release Fentanyl (TIRF) Products Risk Evaluation and Mitigation Strategy (REMS) Education Program for Prescribers and Pharmacists Products Covered Under this Program Abstral (fentanyl)
More informationODACTRA House Dust Mite (Dermatophagoides farina & Dermatophagoides pteronyssinus) allergen extract sublingual tablet
pteronyssinus) allergen extract sublingual tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan.
More informationDispensing and administration of emergency opioid antagonist without a
68-7-23. Dispensing and administration of emergency opioid antagonist without a prescription. (a) A pharmacist may dispense an FDA-approved emergency opioid antagonist and the necessary medical supplies
More informationATI Skills Modules Checklist for Medication Administration 2
For faculty use only Educator s name Score Date ATI Skills Modules Checklist for Medication Administration 2 Student s name Date Verify order Patient record Assess for procedure need Identify, gather,
More informationReview of Prescription and Other Medications and Supplements. Renée M. St. Louis, MPH
Review of Prescription and Other Medications and Supplements Renée M. St. Louis, MPH Meeting the Challenges of Safe Transportation in an Aging Society Symposium September 14, 2016 Acknowledgements Emmy
More informationWITH APPLICATIONS TO : ; : GENERAL AND SPECIALTY AREAS
f Fourth Edition WITH APPLICATIONS TO : ; : GENERAL AND SPECIALTY AREAS Joyce LeFever Kee, RN, MS Associate Professor Emerita College of Health and Nursing Sciences University of Delaware Newark, Delaware
More informationMedication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016
Medication Safety Patient Safety Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 1 The patient journey Admission Ward Transfer Ward stay Discharge Medication storage and supply
More informationPHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION
PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION 1 PHARMACEUTICS Pharmaceutics is the science of dosage form design. The general area of study concerned with the formulation, manufacture, stability, and
More informationIntroduction to. Pharmacokinetics. University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D
Introduction to 1 Pharmacokinetics University of Hawai i Hilo Pre-Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 2 Learning objectives Understand compartment models and how they effects
More informationDDD Support Coordination Updates August 15, 2016
DDD Support Coordination Updates August 15, 2016 Division Announcement Regarding Recent irecord Enhancement After the irecord 3.25 release, users were unable to find some medications and/or dosages that
More informationRegulations: Adult Minimal Sedation
Regulations: Adult Minimal Sedation Jason H. Goodchild, DMD DrGoodchild@yahoo.com April 2017 Regulations Caveats 1. The regulations about to be presented are accurate and current as of today. 2. This could
More informationDrug CHAPTER 2. Pharmacologic Principles. NDEG 26A Eliza Rivera-Mitu, RN, MSN. Pharmacology. Drug Names. Pharmacologic Principles. Drug Names (cont'd)
CHAPTER 2 Pharmacologic Principles NDEG 26A Eliza Rivera-Mitu, RN, MSN Drug Any chemical that affects the physiologic processes of a living organism Pharmacology The study or science of drugs Drug Names
More informationESKATA (hydrogen peroxide) topical solution Initial U.S. Approval: 2017
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ESKATA safely and effectively. See full prescribing information for ESKATA. ESKATA (hydrogen peroxide)
More informationAgency Information Collection Activities; Submission for Office of Management and Budget
This document is scheduled to be published in the Federal Register on 01/28/2016 and available online at http://federalregister.gov/a/2016-01690, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationLesson 5: Recording and Storage of Medication
Lesson 5: Recording and Storage of Medication Transcript Title Slide (no narration) Narrator Slide Hello. My name is Jill Morrow and I am the Medical Director for the Office of Developmental Programs.
More informationPPP 1. Continuation, modification, and discontinuation of a medication
PRESCRIBING POLICIES: 4.7 PHARMACIST AUTHORITY The College of Pharmacists of BC Professional Practice Policy (PPP) 58 Medication Management (Adapting a Prescription) became effective April 1, 2009. The
More informationAsthma Please complete packet and return to nurse at child s school
Health forms for students with Asthma Please complete packet and return to nurse at child s school What s in this packet? 1) Asthma Questionnaire to describe student s asthma 2) Release of Information
More informationINFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:
LESSON PLAN: 5 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,
More informationIN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM
BACKGROUND IN USE PRODUCT SAFETY ASSESSMENT REPORT FOR COLISTIMETHATE SODIUM SUMMARY OF ASSESSMENT AND ITS FINDINGS Colistimethate sodium (colistin sulfomethate sodium) is licensed in the UK to be given
More informationDivision 1 Introduction to Advanced Prehospital Care
Division 1 Introduction to Advanced Prehospital Care Chapter 7 Intravenous Access and Medication Administration Part 1 Principles and Routes of Medication Administration Topics Aseptic Technique Medication
More informationChapter Goal. Learning Objectives 9/11/2012. Chapter 5. Emergency Pharmacology
Chapter 5 Emergency Pharmacology Chapter Goal Understand basic principles of pharmacology, & develop drug profiles for common emergency medications Learning Objectives Differentiate among chemical, generic
More informationPaediatric Prescribing Pocket Guide September 2014 (Version 1)
PAGE 1 Paediatric Prescribing Pocket Guide September 2014 (Version 1) In children, the risk of medication errors is often exacerbated by the need for calculations to determine the dose. Prescribing errors
More informationVitamin & Mineral Supplementation Gastric Bypass & Sleeve Gastrectomy
Vitamin & Mineral Supplementation Gastric Bypass & Sleeve Gastrectomy Vitamin & mineral supplementation is a lifetime habit after surgery to meet your core nutritional needs Vitamin & Mineral Supplementation
More informationPrinciples of Drug Action. Intro to Pharmacology: Principles of Courework Drug Action Intro to Pharmacology
Principles of Drug Action Intro to Pharmacology: Principles of Courework 102.3 Drug Action Intro to Pharmacology Directions Read the PPT and complete R.E.A.D. Assignment. There are videos embedded within
More informationFlexRx 6-Tier. SM Pharmacy Benefit Guide
FlexRx 6-Tier SM Pharmacy Benefit Guide Welcome to FlexRx The AllWays Health Partners FlexRx SM program is built for choice, savings, and convenience with benefits including: Low-cost drug tier for many
More informationPharmacy Coverage Guidelines are subject to change as new information becomes available.
RAGWITEK (Short Ragweed Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage Guideline
More informationSession 2. Data analysis based on overview of EudraVigilance data. Victoria Newbould, EMA, EU. Medication-errors workshop London, 20 October 2016
Session 2 Data analysis based on overview of EudraVigilance data Victoria Newbould, EMA, EU Medication-errors workshop London, 20 October 2016 An agency of the European Union Acknowledgement Steven Le
More information2016 Physician Quality Reporting System Data Collection Form: Chronic Obstructive Pulmonary Disease (COPD) (for patients aged 18 and older)
2016 Physician Quality Reporting System Data Collection Form: Chronic Obstructive Pulmonary Disease (COPD) (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse
More informationCMA response to TGO 92- Standards for the labels of non-prescription medicines
CMA response to TGO 92- Standards for the labels of non-prescription medicines Proposed Requirement TGO 92 Text size Text size equivalent to Arial font has been removed from TGO 92. The definition for
More informationCARD/MAIL/PRE-APPROVAL/PREFERRED RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date:
RIDER FOR PRESCRIPTION DRUG [INSURANCE] [Policy]holder: Group Policy No: Effective Date: CARD/MAIL/PRE-APPROVAL/PREFERRED The Prescription Drug Coverage under this Rider [replaces] [supplements] the Prescription
More informationNANO 243/CENG 207 Course Use Only
L6. Drug Administration & Transport by Fluid Motion April 19, 2018 Part I: Drug Administration Routes of Drug Administration Topical: local effect, substance is applied directly where its action is desired.
More informationEverything You Ever Wanted to Know About the NAPLEX DONALD A GODWIN, PHD INTERIM DEAN UNM COLLEGE OF PHARMACY
Everything You Ever Wanted to Know About the NAPLEX DONALD A GODWIN, PHD INTERIM DEAN UNM COLLEGE OF PHARMACY Objectives AT THE COMPLETION OF THIS ACTIVITY, THE PHARMACIST PARTICIPANT WILL BE ABLE TO:
More informationEverything You Ever Wanted to Know About the NAPLEX DONALD A GODWIN, PHD INTERIM DEAN UNM COLLEGE OF PHARMACY
Everything You Ever Wanted to Know About the NAPLEX DONALD A GODWIN, PHD INTERIM DEAN UNM COLLEGE OF PHARMACY Objectives AT THE COMPLETION OF THIS ACTIVITY, THE PHARMACIST PARTICIPANT WILL BE ABLE TO:
More informationPOSITION STATEMENT. Safer design of vaccines packaging and labelling
2015 POSITION STATEMENT Safer design of vaccines packaging and labelling POSITION STATEMENT The International Medication Safety Network recommends the following steps as part of a comprehensive, worldwide
More informationCalcium Folinate Solution for Injection
1 of 7 6/10/2016 4:14 PM Dosage Form: injection, solution Calcium Folinate Solution for Injection URGENT: LEUCOVORIN UPDATE June 2011 Dear Healthcare Professional: Due to the current critical shortage
More informationCoventry Health Care of Georgia, Inc.
Coventry Health Care of Georgia, Inc. PRESCRIPTION DRUG RIDER (for High Deductible Health Plans) This Prescription Drug Rider is an attachment to the Coventry Health Care of Georgia, Inc. ( Health Plan
More informationINFORMATION TOPIC: II-5 OR DEMONSTRATION: II-5. DOSAGE, MEASUREMENTS, AND DRUG FORMS (Lesson Title) OBJECTIVES THE STUDENT WILL BE ABLE TO:
LESSON PLAN: 5 COURSE TITLE: UNIT: II MEDICATION TECHNICIAN GENERAL PRINCIPLES SCOPE OF UNIT: This unit includes medication terminology, dosage, measurements, drug forms, transcribing physician s orders,
More informationChapter 2 is a general introduction to the drug administration
Chapter 2 Safe and Accurate Drug Administration Chapter Overview Chapter 2 is a general introduction to the drug administration process. It introduces the student to the role of the person who administers
More informationAN OVERVIEW: THE MANAGEMENT OF FEVER IN CHILDREN
AN OVERVIEW: THE MANAGEMENT OF FEVER IN CHILDREN INTRODUCTION Fever is a normal physiological response to illness that facilitates and accelerates recovery. Although there is no evidence that children
More informationMedication Administration Curriculum INSTRUCTOR S MANUAL. Name State Date
Instructions: Circle the letter of the choice that best completes the statement or answers the question. If select modules were presented, only fill out the questions related to those modules. MODULE 1
More informationThe Importance of Treatment Compliance. Health Education Programme targeting the Elderly on the Correct Use of Medicines (PESGG)
The Importance of Treatment Compliance Health Education Programme targeting the Elderly on the Correct Use of Medicines (PESGG) WHAT DOES PROPER USE OF MEDICINES MEAN? WHY DO WE NEED TO USE MEDICINES CORRECTLY?
More information6. SR, XR, CR, and TR are examples of formulations. A) oral B) modified release C) repeat action D) soft gels
1. Which is a parenteral route of administration? A) oral B) vaginal C) sublingual D) rectal 2. A local effect occurs A) at the site of administration. B) throughout the body. C) only after intravenous
More informationGeneral Pharmacology. Henry: EMT Prehospital Care, Revised 3 rd Edition Lecture Notes Chapter 16: General Pharmacology. Case History.
Henry: EMT Prehospital Care, Revised 3 rd Edition Lecture Notes Chapter 16: General Pharmacology Chapter 16 General Pharmacology Slide 1 Case History You arrive at the home of a patient with chest pain.
More informationFundamentals of Pharmacology for Veterinary Technicians Chapter 1
1906 1914 1933 1937 1938 1941 1951 1965 1968 1970 1970 1972 1972 1983 1984 1988 1994 1994 1996 1997 2001 2003 2008 The original Pure Food and Drug Act is passed by Congress on June 30 and signed by President
More information6/7/2017 CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE DISCLOSURE OBJECTIVES
CHANGES IN PHARMA REGULATIONS HOW IT AFFECTS THE OR NURSE John Karwoski, RPh, MBA DISCLOSURE I, John Karwoski, RPH, MBA have business relationships with the companies MOBIUS THERAPEUTICS, LLC, Cubex, and
More informationMedications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.
Medications Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy. What do I need to know about medications after my heart attack? When you
More informationPackage leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid
Package leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid Read all of this leaflet carefully before you are given this medicine because it contains important
More informationSafe Medication Use. Patient Teaching Slides
Safe Medication Use Patient Teaching Slides 3 Ways to Improve Medication Safety 1. Talk to your Doctor or Pharmacist about Your Medications 2. Organize, Store, Secure, and Dispose of Your Medications Safely
More information2014 Oncology Measures Group Overview
2014 Oncology Measures Group Overview The Oncology Measures Group is a reporting option that significantly reduces the burden of participation in the Physician Quality Reporting System (PQRS). Source:
More informationmiconazole and zinc oxide topical
miconazole and zinc oxide topical Pronunciation: mye KON a zole and ZINK OX ide TOP ik al Brand: Rash Relief Antifungal, Vusion What is the most important information I should know about miconazole and
More informationChapter 11 How to state your conditions clearly to the doctor
Chapter 11 How to state your conditions clearly to the doctor Chapter 11 How to state your conditions clearly to the doctor While seeing doctor, details of your statement should include the following:
More informationPRSB e-discharge summary phase 2 Medications and medical devices information model
PRSB e-discharge summary phase 2 Medications and medical devices information model Purpose This paper provides an information model for medications and medical devices. It is based on the discharge summary
More informationMedication Administration and Documentation. A NC Approved CE Class offered by
Medication Administration and Documentation A NC Approved CE Class offered by Common Medical Abbreviations - Doses gm = gram gtt = drop mg = milligram ss = 1/2 mcg = microgram oz = ounce cc = cubic centimeter
More informationYour Medicine: Be Smart. Be Safe.
Your Medicine: Be Smart. Be Safe. Learn more about how to take medicines safely. Use the wallet card at the back of this booklet to keep track of your medicines. Keep this booklet with your medicines and
More informationNEXAVAR (sorafenib tosylate) oral tablet
NEXAVAR (sorafenib tosylate) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
More informationVitamin and Mineral Supplementation and Monitoring. Bariatric Surgery
Vitamin and Mineral Supplementation and Monitoring Bariatric Surgery We put our patients first by working as one team; leading and listening, and striving for the best. Together, we make the difference.
More information201 KAR 8:550. Anesthesia and sedation.
201 KAR 8:550. Anesthesia and sedation. RELATES TO: KRS 313.035 STATUTORY AUTHORITY: KRS 313.035(1) NECESSITY, FUNCTION AND CONFORMITY: KRS 313.035(1) requires the board to promulgate administrative regulations
More informationMedicines and You: A Guide for Older Adults
Medicines and You: A Guide for Older Adults Council on Family Health Provided in cooperation with U.S. Department of Health and Human Services Food and Drug Administration and the Administration on Aging
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 19 October 2011
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 19 October 2011 PEDIAVEN AP-HP G15, solution for infusion 1000 ml of solution in two chamber bag, B/4 (CIP code: 419
More informationSection 5: Appendices
MEDICATION ASSISTANCE IN ASSISTED LIVING Section 5: Appendices Medication Terminology Definitions Abbreviations 60 Appendix A: Medication Terminology There are many terms associated with medications and
More informationFLUOXETINE 60 MG oral tablet FLUOXETINE 90 MG oral delayed release (once weekly) capsule
FLUOXETINE 90 MG oral delayed release (once weekly) capsule Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit
More informationDRAFT PROPOSAL FOR REVISION OF GENERAL MONOGRAPHS: PARENTERAL PREPARATIONS. (July 2012) Draft for comment
1 2 3 4 5 DRAFT PROPOSAL FOR REVISION OF July 2012 RESTRICTED GENERAL MONOGRAPHS: PARENTERAL PREPARATIONS (July 2012) Draft for comment This document was provided by a quality control expert. Should you
More informationUPDATE Ohana QUEST Integration Medicaid
UPDATE Ohana QUEST Integration Medicaid Preferred Drug List June 29, 2015 Dear Provider: At the June 04, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes
More informationAssessment of Human Pharmaceutical Products Registered in Kenya by Route of Administration and Type of Dosage Form
38 East and Central African Journal of Pharmaceutical Sciences Vol. 15 (2012) 38-46 Assessment of Human Pharmaceutical Products Registered in Kenya by Route of Administration and Type of Dosage Form N.N.
More informationPHAR 7632 Chapter 7. Table Market and Share of Pharmaceuticals by ROA Data from Viswanathan, 2004
Student Objectives for this Chapter After completing the material in this chapter each student should:- be able to describe various routes of drug administration including the concentration versus time
More informationAgreed Core Safety Profile for Budesonide nasal spray suspension and Budesonide nasal powder
CSP Drug Budesonide Substance Date 13 Oct 2011 rev 11Nov Supersedes 18 Aug 2011 Agreed Core Safety Profile for DK/H/PSUR/0041/001 TABLE OF CONTENTS PAGE TITLE PAGE... 1 TABLE OF CONTENTS... 2 Introduction...
More informationPRESCRIBING INFORMATION WITH CONSUMER INFORMATION MYDRIACYL. tropicamide ophthalmic solution, USP. 0.5% and 1% w/v.
PRESCRIBING INFORMATION WITH CONSUMER INFORMATION Pr MYDRIACYL tropicamide ophthalmic solution, USP 0.5% and 1% w/v Anticholinergic Alcon Canada Inc. 2665 Meadowpine Blvd. Mississauga, ON L5N 8C7 www.alcon.ca
More informationISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy, Albuquerque, NM. [ NMAC - N, ; A, ]
TITLE 16 CHAPTER 19 PART 26 OCCUPATIONAL AND PROFESSIONAL LICENSING PHARMACISTS PHARMACIST PRESCRIPTIVE AUTHORITY 16.19.26.1 ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy, Albuquerque,
More informationANNUAL FOLLOW-UP QUESTIONNAIRE FORM
O.M.B 0925-0281 Exp. 05312010 ARIC AUAL FOLLOW-UP QUESTIOAIRE FORM Atherosclerosis Risk in Communities ID UMBER: COTACT EAR: FORM CODE: A F U VERSIO: L DATE:060307 LAST AME: IITIALS: Public reporting burden
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr NUCALA [new-ka la] mepolizumab lyophilized powder for subcutaneous injection Read this carefully before you start
More informationPREREQUISITES: VETA 1104, VETA 1201 and MATH This class must be taken before or in conjunction with VETT 2100.
COURSE: VETT 2102 - Pharmacology for Veterinary Technicians CRN: CREDIT HOURS (Lecture/Lab/Total): 3/0/3 CONTACT HOUR (Lecture/Lab/Total): 45/0/45 INSTRUCTOR INFORMATION Name: Shawna Guidry Email: shawnaguidry@northshorecollege.edu
More informationNEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE Thomas R. Frieden, MD, MPH Commissioner
NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE Thomas R. Frieden, MD, MPH Commissioner Interim Guidance on Dosage, Precautions, and Adverse Effects of Antiviral Medications used to Treat or Prevent
More informationPHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 5/18/17 SECTION: DRUGS LAST REVIEW DATE: 5/17/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE:
KARBINAL ER (carbinoxamine maleate) extended release oral suspension Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific
More information